Lineage Cell Therapeutics (LCTX) Notes Payables (2015 - 2019)
Lineage Cell Therapeutics (LCTX) reported Notes Payables of $18000.0 for Q1 2019, down 85.0% on a YoY basis from $120000.0 in Q1 2018, and down 74.29% quarter-over-quarter from $70000.0 in Q4 2018.
Lineage Cell Therapeutics (LCTX) Notes Payables (2015 - 2019) Analysis & Trends
Lineage Cell Therapeutics has reported Notes Payables for 5 years, with the latest figure at $18000.0 in Q1 2019.
- For the quarter ending Q1 2019, Notes Payables fell 85.0% year-over-year to $18000.0; the trailing twelve-month figure through Mar 2019 stood at $18000.0 (down 85.0% YoY), and the FY2018 full-year result was $70000.0, down 53.95% from the prior year.
- Notes Payables for Q1 2019 stood at $18000.0, down from $70000.0 in the prior quarter.
- The five-year high for Notes Payables was $2.6 million in Q2 2017, with the low at $13000.0 in Q3 2017.
- Historically, Notes Payables has averaged $253375.0 across 5 years, with a median of $95000.0 in 2015.
- Annual changes were most pronounced in 2017 — Notes Payables jumped 2589.47% — and 2018, when it sank 95.3%.
- Lineage Cell Therapeutics' Notes Payables stood at $95000.0 in 2015, then gained by 4.21% to $99000.0 in 2016, then soared by 53.54% to $152000.0 in 2017, then slumped by 53.95% to $70000.0 in 2018, then sank by 74.29% to $18000.0 in 2019.
- The last three Notes Payables figures came in at $18000.0 (Q1 2019), $70000.0 (Q4 2018), and $70000.0 (Q3 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 18,000.00 |
| Dec 31, 2018 | 70,000.00 |
| Sep 30, 2018 | 70,000.00 |
| Jun 30, 2018 | 120,000.00 |
| Mar 31, 2018 | 120,000.00 |
| Dec 31, 2017 | 152,000.00 |
| Sep 30, 2017 | 13,000.00 |
| Jun 30, 2017 | 2.56 Mn |
| Mar 31, 2017 | 124,000.00 |
| Dec 31, 2016 | 99,000.00 |
| Sep 30, 2016 | 95,000.00 |
| Jun 30, 2016 | 95,000.00 |
| Mar 31, 2016 | 95,000.00 |
| Dec 31, 2015 | 95,000.00 |
| Sep 30, 2015 | 95,000.00 |
| Jun 30, 2015 | 238,000.00 |